Cargando…

Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay

The interferon-induced transmembrane proteins 1–3 (IFITM1–3) inhibit host cell entry of several viruses. However, it is incompletely understood how IFITM1–3 exert antiviral activity. Two phenylalanine residues, F75 and F78, within the intramembrane domain 1 (IM1) were previously shown to be required...

Descripción completa

Detalles Bibliográficos
Autores principales: Winkler, Michael, Wrensch, Florian, Bosch, Pascale, Knoth, Maike, Schindler, Michael, Gärtner, Sabine, Pöhlmann, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719045/
https://www.ncbi.nlm.nih.gov/pubmed/31398796
http://dx.doi.org/10.3390/ijms20163859
_version_ 1783447851392565248
author Winkler, Michael
Wrensch, Florian
Bosch, Pascale
Knoth, Maike
Schindler, Michael
Gärtner, Sabine
Pöhlmann, Stefan
author_facet Winkler, Michael
Wrensch, Florian
Bosch, Pascale
Knoth, Maike
Schindler, Michael
Gärtner, Sabine
Pöhlmann, Stefan
author_sort Winkler, Michael
collection PubMed
description The interferon-induced transmembrane proteins 1–3 (IFITM1–3) inhibit host cell entry of several viruses. However, it is incompletely understood how IFITM1–3 exert antiviral activity. Two phenylalanine residues, F75 and F78, within the intramembrane domain 1 (IM1) were previously shown to be required for IFITM3/IFITM3 interactions and for inhibition of viral entry, suggesting that IFITM/IFITM interactions might be pivotal to antiviral activity. Here, we employed a fluorescence resonance energy transfer (FRET) assay to analyze IFITM/IFITM interactions. For assay calibration, we equipped two cytosolic, non-interacting proteins, super yellow fluorescent protein (SYFP) and super cyan fluorescent protein (SCFP), with signals that target proteins to membrane rafts and also analyzed a SCFP-SYFP fusion protein. This strategy allowed us to discriminate background signals resulting from colocalization of proteins at membrane subdomains from signals elicited by protein–protein interactions. Coexpression of IFITM1–3 and IFITM5 fused to fluorescent proteins elicited strong FRET signals, and mutation of F75 and F78 in IFITM3 (mutant IFITM3-FF) abrogated antiviral activity, as expected, but did not alter cellular localization and FRET signals. Moreover, IFITM3-FF co-immunoprecipitated efficiently with wild type (wt) IFITM3, lending further support to the finding that lack of antiviral activity of IFITM3-FF was not due to altered membrane targeting or abrogated IFITM3-IFITM3 interactions. Collectively, we report an assay that allows quantifying IFITM/IFITM interactions. Moreover, we confirm residues F75 and F78 as critical for antiviral activity but also show that these residues are dispensable for IFITM3 membrane localization and IFITM3/IFITM3 interactions.
format Online
Article
Text
id pubmed-6719045
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67190452019-09-10 Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay Winkler, Michael Wrensch, Florian Bosch, Pascale Knoth, Maike Schindler, Michael Gärtner, Sabine Pöhlmann, Stefan Int J Mol Sci Article The interferon-induced transmembrane proteins 1–3 (IFITM1–3) inhibit host cell entry of several viruses. However, it is incompletely understood how IFITM1–3 exert antiviral activity. Two phenylalanine residues, F75 and F78, within the intramembrane domain 1 (IM1) were previously shown to be required for IFITM3/IFITM3 interactions and for inhibition of viral entry, suggesting that IFITM/IFITM interactions might be pivotal to antiviral activity. Here, we employed a fluorescence resonance energy transfer (FRET) assay to analyze IFITM/IFITM interactions. For assay calibration, we equipped two cytosolic, non-interacting proteins, super yellow fluorescent protein (SYFP) and super cyan fluorescent protein (SCFP), with signals that target proteins to membrane rafts and also analyzed a SCFP-SYFP fusion protein. This strategy allowed us to discriminate background signals resulting from colocalization of proteins at membrane subdomains from signals elicited by protein–protein interactions. Coexpression of IFITM1–3 and IFITM5 fused to fluorescent proteins elicited strong FRET signals, and mutation of F75 and F78 in IFITM3 (mutant IFITM3-FF) abrogated antiviral activity, as expected, but did not alter cellular localization and FRET signals. Moreover, IFITM3-FF co-immunoprecipitated efficiently with wild type (wt) IFITM3, lending further support to the finding that lack of antiviral activity of IFITM3-FF was not due to altered membrane targeting or abrogated IFITM3-IFITM3 interactions. Collectively, we report an assay that allows quantifying IFITM/IFITM interactions. Moreover, we confirm residues F75 and F78 as critical for antiviral activity but also show that these residues are dispensable for IFITM3 membrane localization and IFITM3/IFITM3 interactions. MDPI 2019-08-08 /pmc/articles/PMC6719045/ /pubmed/31398796 http://dx.doi.org/10.3390/ijms20163859 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Winkler, Michael
Wrensch, Florian
Bosch, Pascale
Knoth, Maike
Schindler, Michael
Gärtner, Sabine
Pöhlmann, Stefan
Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay
title Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay
title_full Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay
title_fullStr Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay
title_full_unstemmed Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay
title_short Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay
title_sort analysis of ifitm-ifitm interactions by a flow cytometry-based fret assay
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719045/
https://www.ncbi.nlm.nih.gov/pubmed/31398796
http://dx.doi.org/10.3390/ijms20163859
work_keys_str_mv AT winklermichael analysisofifitmifitminteractionsbyaflowcytometrybasedfretassay
AT wrenschflorian analysisofifitmifitminteractionsbyaflowcytometrybasedfretassay
AT boschpascale analysisofifitmifitminteractionsbyaflowcytometrybasedfretassay
AT knothmaike analysisofifitmifitminteractionsbyaflowcytometrybasedfretassay
AT schindlermichael analysisofifitmifitminteractionsbyaflowcytometrybasedfretassay
AT gartnersabine analysisofifitmifitminteractionsbyaflowcytometrybasedfretassay
AT pohlmannstefan analysisofifitmifitminteractionsbyaflowcytometrybasedfretassay